1 false false false false false false false false false false true false false false false false false No description of principal activity 2024-08-01 Sage Accounts Production Advanced 2023 - FRS102_2023 xbrli:pure xbrli:shares iso4217:GBP 12094384 2024-08-01 2025-07-31 12094384 2025-07-31 12094384 2024-07-31 12094384 2023-08-01 2024-07-31 12094384 2024-07-31 12094384 2023-07-31 12094384 bus:Director1 2024-08-01 2025-07-31 12094384 core:WithinOneYear 2025-07-31 12094384 core:WithinOneYear 2024-07-31 12094384 bus:Micro-entities 2024-08-01 2025-07-31 12094384 bus:AuditExemptWithAccountantsReport 2024-08-01 2025-07-31 12094384 bus:SmallCompaniesRegimeForAccounts 2024-08-01 2025-07-31 12094384 bus:PrivateLimitedCompanyLtd 2024-08-01 2025-07-31 12094384 bus:FullAccounts 2024-08-01 2025-07-31
COMPANY REGISTRATION NUMBER: 12094384
AA MEDICAL ENTERPRISE LTD
Filleted Unaudited Financial Statements
31 July 2025
AA MEDICAL ENTERPRISE LTD
Statement of Financial Position
31 July 2025
2025
2024
£
£
Current assets
115,579
80,354
Creditors: amounts falling due within one year
43,989
38,830
---------
--------
Net current assets
71,590
41,524
--------
--------
Total assets less current liabilities
71,590
41,524
Accruals and deferred income
2,880
1,920
--------
--------
68,710
39,604
--------
--------
Capital and reserves
68,710
39,604
--------
--------
Notes to the financial statements
1. Employee numbers
The average number of persons employed by the company during the year amounted to 1 (2024: 1 ).
For the year ending 31 July 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
Director's responsibilities:
- The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476 ;
- The director acknowledges her responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of financial statements .
These financial statements have been prepared in accordance with the micro-entity provisions and have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.
These financial statements were approved by the board of directors and authorised for issue on 28 April 2026 , and are signed on behalf of the board by:
Dr A Arora
Director
Company registration number: 12094384
The company is a private company limited by shares, registered in England and Wales. The address of the registered office is 35 Ruddlesway, Windsor, Berkshire, SL4 5SF.